Cargando…

Ursachen visueller Halluzinationen bei der Parkinson-Krankheit

BACKGROUND: Visual hallucinations (VH) have mainly been considered as late symptoms of Parkinson’s disease (PD); however, minor forms of VH also occur in early stages of the disease. Initially dopaminergic overstimulation was discussed as the cause and later on VH have been considered as an early re...

Descripción completa

Detalles Bibliográficos
Autor principal: Diederich, Nico J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010390/
https://www.ncbi.nlm.nih.gov/pubmed/34342675
http://dx.doi.org/10.1007/s00115-021-01165-2
Descripción
Sumario:BACKGROUND: Visual hallucinations (VH) have mainly been considered as late symptoms of Parkinson’s disease (PD); however, minor forms of VH also occur in early stages of the disease. Initially dopaminergic overstimulation was discussed as the cause and later on VH have been considered as an early red flag of dementia in PD. OBJECTIVE: The present study analyzed whether the pathophysiological concept of VH has been enlarged in recent years. MATERIAL AND METHODS: Clinical, pharmacological, neuropathological as well as functional magnetic resonance imaging studies dealing with VH were reviewed. A systematic classification in monomodal and multimodal models of VH is proposed. The applicability to various forms of VH and various triggering situations is critically examined. RESULTS: Reduction of the visual information input, erroneous visual processing, attention deficits, and dysfunctional connectivity between various cerebral networks have been shown. There is partial overlapping with the Lhermitte syndrome and the Charles Bonnet syndrome. No model is able to fully explain all VH variants. Not all VH have the same pathogenesis and the same poor prognosis. CONCLUSION: The chain of causes underlying VH is complex and can vary from patient to patient. So far the therapeutic applications are largely unexplored; however, there is preliminary evidence that beside adjustment of the medication, improvement of visual acuity, active involvement of the partner, and possibly, individually adaptable coping strategies could be successfully implemented.